The chronic cholestasis enigma in adults

Israel Medical Association Journal

Volumn 4, Issue 6, 2002, Pages 449-453

  Reshef, Ron ^a   Sbeit, Wisam ^a   Lachter, Jesse ^a  

^a WESTERN GALILEE HOSPITAL   (Israel)

Author keywords

Algorithm; Autoantibodies; Cholestasis; Endoscopic retrograde cholangiopancreatography; Endoscopic ultrasound; Liver biopsy; Magnetic resonance cholangiopancreatography

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMYLASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; BILIRUBIN; CALCIUM; COLCHICINE; CORTICOSTEROID; GAMMA GLUTAMYLTRANSFERASE; GLOBULIN; HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MESALAZINE; MITOCHONDRION ANTIBODY; NALTREXONE; PREDNISONE; PROPRANOLOL; SALAZOSULFAPYRIDINE; SMOOTH MUSCLE ANTIBODY; STEROID; URSODEOXYCHOLIC ACID; VITAMIN D;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALGORITHM; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANAMNESIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; CHRONIC DISEASE; CLINICAL TRIAL; COLONOSCOPY; DISEASE SEVERITY; DOPPLER FLOWMETRY; DRUG MEGADOSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME BLOOD LEVEL; ESOPHAGUS VARICES; GASTROSCOPY; GRANULOMA; HEPATOSPLENOMEGALY; HUMAN; INFLAMMATION; INTRAHEPATIC BILE DUCT; JAUNDICE; LABORATORY TEST; LIVER BIOPSY; LIVER DISEASE; LIVER SCINTISCANNING; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; META ANALYSIS; PHYSICAL EXAMINATION; PORTAL HYPERTENSION; PORTAL VEIN; PROTEIN BLOOD LEVEL; PRURITUS; REVIEW; SCLEROSING CHOLANGITIS; STENT; ULCERATIVE COLITIS; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; MALE; MIDDLE AGED;

ADULT; ALGORITHMS; CHOLESTASIS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0035983144     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. The syndrome of disappearing bile ducts
2. Variant forms of cholestatic diseases involving small bile ducts in adults
3. Primary biliary cirrhosis: Clarifying the issues
4. New knowledge in primary biliary cirrhosis
5. New concepts in biliary cirrhosis
6. Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis
7. Is mitochondrial antibody diagnostic of primary biliary cirrhosis?
8. Serological markers of primary biliary cirrhosis: Diagnosis, prognosis and subsets
9. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: Definition and clinical relevance
10. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2
11. Combined analysis of French, American and Canadian randomized controlled trials of ursodeoxycholic acid therapy in primary biliary cirrhosis
12. Long term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
13. Randomised controlled trials of ursodeoxycholic acid therapy for primary biliary cirrhosis: A meta-analysis
14. Relationship of inflammatory bowel disease and primary sclerosing cholangitis
15. Etiology and pathogenesis in primary sclerosing cholangitis
16. Etiology and natural history of primary sclerosing cholangitis
17. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease
18. Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis
19. Primary intrahepatic obliterating cholangitis: A possible variant of sclerosing cholangitis
20. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis
21. Pericholangitis in chronic ulcerative colitis: Primary sclerosing cholangitis of the small bile ducts?
22. Small-duct primary sclerosing cholangitis
23. Hepatobiliary disease in inflammatory bowel disease
24. A cholangitis with antinuclear antibodies (immunocholangitis) resembling chronic destructive non-suppurative cholangitis
25. Autoimmune cholangiopathy: Parts of the spectrum of autoimmune hepatitis
26. Antimitochondrial antibody negative primary biliary cirrhosis: A distinct syndrome of autoimmune cholangitis
27. Autoimmune cholangitis: A variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases
28. Primary autoimmune hepatitis cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis
29. Autoimmune cholangitis: Another indication for ursodeoxycholic acid therapy
30. Idiopathic adult ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis
31. Idiopathic adulthood ductopenia: An update
32. Idiopathic biliary ductopenia in adults: A report of five cases
33. Idiopathic adulthood ductopenia
34. Idiopathic biliary ductopenia in adults without symptoms of liver disease
35. Idiopathic adult ductopenia. Case report and review of the literature
36. Variant forms of cholestatic diseases involving small bile ducts in adults
37. Cholestyramine therapy in patients with paucity of intrahepatic bile ducts
38. The decision-making value of magnetic resonance cholangiopancreatography in patients seen in referral centers for suspected biliary and pancreatic disease
39. Helical CT cholangiography with three-dimensional volume rendering using an oral biliary contrast agent: Feasibility of a novel technique
40. Complications of gastrointestinal radiologic procedures. II. Complications related to biliary tract studies